e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Boston Scientific (NY:BSX)

97.09 +1.61 (+1.69%)

Streaming Delayed Price Updated: 1:16 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Boston Scientific Earnings Top; BSX Stock Just Below Buy Point ↗

July 27, 2021

Boston Scientific earnings and revenue beat Q2 views for the medtech giant. BSX stock rose to just below a buy point.

Via Investor's Business Daily

Boston Scientific Earnings Exceed Expectations As Demand Picks Up, Raises FY21 Guidance ↗

July 27, 2021

Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.1 billion in Q2 of 2021, beating the estimate of $2.9 billion. Sales increased 53.6% Y/Y on a...

Via Benzinga

Recap: Boston Scientific Q2 Earnings ↗

July 27, 2021

Shares of Boston Scientific (NYSE:BSX) fell 1.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year...

Via Benzinga

Unusual Options Activity Insight: Boston Scientific ↗

July 01, 2021

Boston Scientific (NYSE:BSX) shares experienced unusual options activity on Thursday. The stock price moved up to $43.24 following the option alert. Sentiment: BULLISH Option...

Via Benzinga

Understanding Boston Scientific's Unusual Options Activity ↗

June 30, 2021

Shares of Boston Scientific (NYSE:BSX) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $42.7. Sentiment:...

Via Benzinga

Boston Scientific's Debt Overview ↗

June 24, 2021

Over the past three months, shares of Boston Scientific (NYSE:BSX) rose by 12.01%. Before we understand the importance of debt, let us look at how much debt Boston...

Via Benzinga

Why Boston Scientific's Stock Is Trading Lower Today ↗

May 26, 2021

Boston Scientific (NYSE:BSX) shares are trading lower af...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 23, 2021

On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

Earnings Scheduled For July 27, 2021 ↗

July 27, 2021

Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million....

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Better Buy: Medtronic or Boston Scientific? ↗

June 03, 2021

Which one of these medical device makers is better poised for a breakout year?

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2021 ↗

May 26, 2021

Upgrades Bernstein upgraded the previous rating for Wipro Ltd (NYSE:WIT) from Underperform to Market Perform. Wipro earned $0.07 in the fourth quarter, compared to $0.05...

Via Benzinga

Pete Najarian Sees Unusual Options Activity In Boston Scientific And Deutsche Bank ↗

May 24, 2021

On CNBC's "Fast Money Halftime Report," Pete Najarian spoke about unusually high options activity in Boston Scientific Corporation (NYSE: BSX) and Deutsche Bank AG (...

Via Benzinga

BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX

May 14, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

Pipelines Are ESG ↗

May 02, 2021

ESG is in the eye of the beholder. My favorite is Lockheed Martin, a perennial member of the Dow Jones Sustainability Index. If building weapons to blow up people and property can be done in a...

Via Talk Markets

Topics Stocks

Pete Najarian Sees Unusual Option Activity In Boston Scientific And Las Vegas Sands ↗

April 30, 2021

On CNBC's "Fast Money Halftime Report," Pete Najarian gave some unusual option activity plays. Najarian sees unusual activity in: Boston Scientific (NYSE: BSX) May $...

Via Benzinga

Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon ↗

April 30, 2021

The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded.

Via Investor's Business Daily

Boston Scientific Stock Jumps On Q1 Earnings Beat, Improved Guidance ↗

April 28, 2021

Boston Scientific Corporation (NYSE: BSX) Q1 sales grew by 5.9% (organically) to $2.75 billion, beating the previous guidance range between negative...

Via Benzinga

Topics Earnings

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

Boston Scientific Corp (BSX) Q1 2021 Earnings Call Transcript ↗

April 28, 2021

BSX earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

Boston Scientific: Q1 Earnings Insights ↗

April 28, 2021

Shares of Boston Scientific (NYSE:BSX) moved higher by 2.9% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 32....

Via Benzinga

Boston Scientific Earnings Beat, Guidance Raised; BSX Clears Buy Point ↗

April 28, 2021

Boston Scientific earnings beat views, with the medical products giant also raising full-year EPS guidance. BSX stock rose back into a buy zone.

Via Investor's Business Daily

Topics Earnings

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

Cramer Gives His Opinion On Snap, Cleveland-Cliffs And More ↗

April 22, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Snap Inc (NYSE: SNAP) is going to have a great quarter. It has tremendous growth and Cramer is a buyer. Regal...

Via Benzinga

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX

April 16, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗

April 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy